Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 7:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1465–1488 of 1,736 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: work therapy Clear all

Conditions: Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis, Cardiotoxicity, Cardiovascular Diseases
Interventions: anonymized data collection during programmed surveillance clinical follow up; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Alpha-1 Antitrypsin Deficiency, AAT Deficiency, AATD, Cystic Fibrosis (CF)
Interventions: History and physical exam., Blood draw., Pulmonary function testing., Albuterol inhaler.; Procedure · Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2033
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Malignant Pleural Disease, Mesothelioma, Metastases, Lung Cancer, Breast Cancer
Interventions: iCasp9M28z T cell infusions, cyclophosphamide, pembrolizumab; Genetic · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 6
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 3 more

Conditions: Mental Disorders, Severe, Mental Illness Persistent
Interventions: Park-based physical activity, Active Control; Behavioral
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Augusta, Georgia • Junction City, Kansas

Conditions: Schizophrenia
Interventions: Cognitive remediation therapy; Behavioral
Lead sponsor: Manhattan Psychiatric Center; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Traumatic Brain Injury
Interventions: body weight supported treadmill training, traditional physical therapy; Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 60 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 2
States / cities: Galveston, Texas • Houston, Texas

Conditions: Shift-Work Related Sleep Disturbance
Interventions: Lemborexant, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 20 Years to 60 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Schizophrenia, Bipolar Disorder, Depression, Psychotic Disorders
Interventions: aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine, Psychoeducational multifamily group treatment, Supported employment and education; Drug · Behavioral
Lead sponsor: MaineHealth; Other
Eligibility: 12 Years to 25 Years
Enrollment: 292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 6
States / cities: Sacramento, California • Portland, Maine • Ann Arbor, Michigan + 3 more

Conditions: Depression, Anxiety
Interventions: Lumen Coached PST Intervention., Human Coached PST Intervention., Optional (delayed) Lumen Coached PST (Waitlist control).; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Major Depression, Sleep
Interventions: TMS; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Premenstrual Syndrome, Premenstrual Dysphoric Disorder, Dysmenorrhea, Endometriosis, Perimenopause, Menopause, Pelvic Pain
Interventions: Lutea Transcranial Direct Current Stimulation (tDCS) Device, Samphire Guided Care Program; Device · Behavioral
Lead sponsor: Samphire Group, Inc.; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Low Back Pain, Chronic Pain, Military Personnel, Veterans
Interventions: Physical Therapy, Move 2 Health (M2H), MORE Mindfulness; Behavioral
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 4
States / cities: Schofield Barracks, Hawaii • San Antonio, Texas • Tacoma, Washington

Conditions: Substance Use, Sexual Risk Behaviors
Interventions: Risk Reduction Therapy for Adolescents, Usual services; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 12 Years to 17 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Carpal Tunnel Syndrome
Interventions: Academic Coursework, Work-Related Hand Activities; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2023
U.S. locations: 3
States / cities: Loma Linda, California • Los Angeles, California

Conditions: Suicidal Ideation
Interventions: STAT-PC, YST-III; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 24 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pain, Substance Use, Opioid Misuse, Quality of Life
Interventions: M2VA Pain Care Pathway (M2VAPCP), Implementation Facilitation; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 1,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Anxiety Disorders, Depressive Disorder, Substance Use Disorders
Interventions: Outdoor Behavioral Healthcare (OBH), Cognitive Behavioral Therapy (CBT); Behavioral
Lead sponsor: University of New Hampshire; Other
Eligibility: 13 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Durham, New Hampshire

Conditions: Depressive Disorder
Interventions: Carbidopa/levodopa, Placebo, Exercise training, Control; Drug · Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 60 Years to 100 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer Disease and Related Dementias, Cognition, Mobility Disability
Interventions: Personalized Transcranial Direct Current Stimulation (tDCS), Active-Sham; Other
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 65 Years to 90 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Roslindale, Massachusetts

Conditions: Copd, Asthma, Respiratory Effort, Contactless Vital Sign Monitoring
Interventions: Investigational Device: Contactless heart rate and respiratory rate monitor, Heart Rate (EKG) Monitor, Respiratory rate Monitor, Pulse Oximetry; Device · Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Prostate Cancer
Interventions: Exercise Program, Diet and Nutrition Coaching, Usual Care with Attention; Behavioral · Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 21 Years and older · Male only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Los Angeles, California • Kansas City, Kansas

Conditions: Respiratory Distress, Lung Injury
Interventions: Heated Humidified High Flow Nasal Cannula, Nasal Continuous Positive Airway Pressure; Device
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Hours to 72 Hours
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Placebo, Tiotropium, Olodaterol, Tiotropium + Olodaterol, Respimat; Drug · Device
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 8
States / cities: Torrance, California • Hartford, Connecticut • Livonia, Michigan + 5 more

Conditions: Duchenne Muscular Dystrophy
Interventions: Transdiagnostic Behavioral Sleep Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 6 Years to 18 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Global Cardio Oncology Registry

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Physical Activity to Reduce Cardiometabolic Risk in Adults With Serious Mental Illness (PARCS) Study

Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training

Physical Work Capacity After Traumatic Brain Injury

Lemborexant Shift Work Treatment Study

Early Detection and Intervention for the Prevention of Psychosis

Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor(SPEAC) for Adults With Emotional Distress (Phase 2)

Sleep TMS for Depression

CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life

SMART Stepped Care Management for Low Back Pain in the Military Health System

Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth

Musculoskeletal Health of the Upper Extremity in Emerging Health Professionals

Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas

M2VA Pain Care Pathway

Treating Adolescents With CBT and OBH

Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing

Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome

Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients

Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men

Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

Sleep Intervention in Young Boys with Duchenne Muscular Dystrophy